Latest Comments

A brighter future for rheumatoid arthritis patients?

A brighter future for rheumatoid arthritis patients?

Will FDA guidance on interchangeability help or hinder biosimilar market growth?

Will FDA guidance on interchangeability help or hinder biosimilar market growth?

Low Drug Compliance in Lupus: Are Patients Really to Blame?

Low Drug Compliance in Lupus: Are Patients Really to Blame?

Will a focus on oncology bring blockbuster success?

Will a focus on oncology bring blockbuster success?

The emergence of oncology biosimilars

The emergence of oncology biosimilars

CDK4/6 inhibitor rivalry in breast cancer begins

CDK4/6 inhibitor rivalry in breast cancer begins

BMS to have their cake and eat it with Keytruda settlement

BMS to have their cake and eat it with Keytruda settlement

Roche’s Tecentriq pulls further ahead in metastatic bladder cancer

Roche’s Tecentriq pulls further ahead in metastatic bladder cancer

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer

Elagolix launch is welcome, but it won't be a cure-all for endometriosis

Elagolix launch is welcome, but it won't be a cure-all for endometriosis

Rule-breakers: rehabilitating wayward clinical researchers

Rule-breakers: rehabilitating wayward clinical researchers

Could copper unlock a new wave of metabolic treatments?

Could copper unlock a new wave of metabolic treatments?

Lupus breakthrough sparks hope in a frustrating field

Lupus breakthrough sparks hope in a frustrating field